Cart
sales@molnova.com
Methylswertianin
CAS No. 22172-17-4
Methylswertianin( ——— )
Catalog No. M38788 CAS No. 22172-17-4
Methylswertianin is an active constituent in Swertia punicea Hemsl, with anti-diabetic effect. Methylswertianincan abates type-2 diabetes, likely via the improvement of insulin resistance (IR).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 452 | Get Quote |
|
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMethylswertianin
-
NoteResearch use only, not for human use.
-
Brief DescriptionMethylswertianin is an active constituent in Swertia punicea Hemsl, with anti-diabetic effect. Methylswertianincan abates type-2 diabetes, likely via the improvement of insulin resistance (IR).
-
DescriptionSwertiaperennin is a natural product
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number22172-17-4
-
Formula Weight288.25
-
Molecular FormulaC15H12O6
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tian LY, et al. Anti-diabetic effect of methylswertianin and bellidifolin from Swertia punicea Hemsl. and its potential mechanism. Phytomedicine. 2010 Jun;17(7):533-9.?
molnova catalog
related products
-
Amino-PEG12-amine
Amino-PEG12-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
Pseudolaric acid A-O...
Pseudolaric acid A-O-beta-D-glucopyranoside is a natural product with antibacterial, anticancer.
-
6-Hydroxykaempferol ...
6-Hydroxykaempferol 3,6-di-O-glucoside and 6-hydroxykaempferol 3,6,7-tri-O-glucoside can inhibit platelet aggregation induced by collagen, they also show weak inhibitory effects on the adenosine 5'-diphosphate (ADP)- induced platelet aggregation.
